Jeevan Utthan Health House Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 17-07-2024
- Paid Up Capital ₹ 0.10 M
as on 17-07-2024
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit -2371.02%
(FY 2023)
- Ebitda -3547.89%
(FY 2023)
- Net Worth -807.14%
(FY 2023)
- Total Assets 976.55%
(FY 2023)
About Jeevan Utthan Health House
The Corporate was formerly known as Swarnima Fashions Private Limited. The Company is engaged in the Fashion And Textile Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjib Mondal, Sarbojeet Lahiri, and Padam Mittal serve as directors at the Company.
- CIN/LLPIN
U52190WB2012PTC185983
- Company No.
185983
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Sep 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jeevan Utthan Health House?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sarbojeet Lahiri  | Director | 20-Apr-2022 | Current |
| Sanjib Mondal | Director | 15-Jul-2014 | Current |
| Padam Mittal | Director | 20-Apr-2022 | Current |
Financial Performance and Corporate Structure Insights of Jeevan Utthan Health House.
Jeevan Utthan Health House Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 2371.02% decrease in profit. The company's net worth observed a substantial decline by a decrease of 807.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jeevan Utthan Health House?
In 2023, Jeevan Utthan Health House had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Sanjivani Business And Trade Consultants LlpActive 5 years 6 months
Sanjib Mondal and Padam Mittal are mutual person
- Sanjivani Portfolio Services Private LimitedActive 13 years 1 month
Sanjib Mondal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jeevan Utthan Health House?
Unlock and access historical data on people associated with Jeevan Utthan Health House, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jeevan Utthan Health House, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jeevan Utthan Health House's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
